360 Harnessing the potential of autologous NK cells for immunotherapy of patients with advanced bladder cancer

• Amineh Ghaderi,
• Fernanda Costa Svedman,
• Mahin Nikougoftar Zarif,
• Zahra Rajabkhani,
• Johan Liwing,
• Anna-Karin Maltais,
• Anders Ullén

Affiliations

Amineh Ghaderi

1XNK Therapeutics, Stockholm, Sweden

Fernanda Costa Svedman

2Karolinska Universitetssjukhuset, Stockholm, Sweden

Mahin Nikougoftar Zarif

1XNK Therapeutics, Stockholm, Sweden

Zahra Rajabkhani

1XNK Therapeutics, Stockholm, Sweden

Johan Liwing

1XNK Therapeutics, Stockholm, Sweden

Anna-Karin Maltais

1XNK Therapeutics, Stockholm, Sweden

Anders Ullén

3Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden